ID   A549 PIP4P1 KO
AC   CVCL_D3VW
SY   A549 TMEM55B KO
RX   DOI=10.1101/2023.06.07.544051;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 19299; PIP4P1.
CC   Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 30-01-24; Version: 1
//
RX   DOI=10.1101/2023.06.07.544051;
RA   Pal P., Taylor M., Lam P.Y., Tonelli F., Hecht C.A., Lis P.,
RA   Nirujogi R.S., Phung T.K., Dickie E.A., Wightman M., Macartney T.,
RA   Pfeffer S.R., Alessi D.R.;
RT   "Parkinson's VPS35[D620N] mutation induces LRRK2 mediated lysosomal
RT   association of RILPL1 and TMEM55B.";
RL   bioRxiv 2023:06.07.544051-06.07.544051(2023).
//